The stock of Rockwell Medical Inc (RMTI) has gone up by 13.72% for the week, with a 31.40% rise in the past month and a 81.09% rise in the past quarter. The volatility ratio for the week is 6.92%, and the volatility levels for the past 30 days are 6.05% for RMTI. The simple moving average for the last 20 days is 15.20% for RMTI stock, with a simple moving average of 92.60% for the last 200 days.
Is It Worth Investing in Rockwell Medical Inc (NASDAQ: RMTI) Right Now?
The 36-month beta value for RMTI is also noteworthy at 1.52. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 1 rating it as “hold,” and 1 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for RMTI is 27.16M, and at present, short sellers hold a 3.03% of that float. The average trading volume of RMTI on November 08, 2024 was 566.51K shares.
RMTI) stock’s latest price update
Rockwell Medical Inc (NASDAQ: RMTI)’s stock price has increased by 2.86 compared to its previous closing price of 4.19. However, the company has seen a 13.72% increase in its stock price over the last five trading sessions. businesswire.com reported 2024-11-08 that WIXOM, Mich.–(BUSINESS WIRE)—- $RMTI #EndStageKidneyDisease–UPDATED Q3’24 EARNINGS DATE: Rockwell Medical will release its third quarter 2024 financial and operational results on November 12, 2024.
Analysts’ Opinion of RMTI
Many brokerage firms have already submitted their reports for RMTI stocks, with Piper Jaffray repeating the rating for RMTI by listing it as a “Overweight.” The predicted price for RMTI in the upcoming period, according to Piper Jaffray is $10 based on the research report published on June 24, 2019 of the previous year 2019.
H.C. Wainwright, on the other hand, stated in their research note that they expect to see RMTI reach a price target of $11. The rating they have provided for RMTI stocks is “Buy” according to the report published on May 13th, 2019.
RMTI Trading at 16.88% from the 50-Day Moving Average
After a stumble in the market that brought RMTI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -5.69% of loss for the given period.
Volatility was left at 6.05%, however, over the last 30 days, the volatility rate increased by 6.92%, as shares surge +23.96% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +45.54% upper at present.
During the last 5 trading sessions, RMTI rose by +12.51%, which changed the moving average for the period of 200-days by +209.00% in comparison to the 20-day moving average, which settled at $3.74. In addition, Rockwell Medical Inc saw 128.04% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at RMTI starting from Chole Timothy, who sale 1,001 shares at the price of $3.69 back on Oct 01 ’24. After this action, Chole Timothy now owns 55,171 shares of Rockwell Medical Inc, valued at $3,689 using the latest closing price.
Strobeck Mark, the President and CEO of Rockwell Medical Inc, sale 2,163 shares at $3.69 during a trade that took place back on Oct 01 ’24, which means that Strobeck Mark is holding 147,201 shares at $7,971 based on the most recent closing price.
Stock Fundamentals for RMTI
Current profitability levels for the company are sitting at:
- -0.03 for the present operating margin
- 0.13 for the gross margin
The net margin for Rockwell Medical Inc stands at -0.05. The total capital return value is set at -0.08. Equity return is now at value -29.25, with -10.61 for asset returns.
Based on Rockwell Medical Inc (RMTI), the company’s capital structure generated 0.32 points at debt to capital in total, while cash flow to debt ratio is standing at -0.43. The debt to equity ratio resting at 0.47. The interest coverage ratio of the stock is -6.21.
Currently, EBITDA for the company is -5.23 million with net debt to EBITDA at -1.26. When we switch over and look at the enterprise to sales, we see a ratio of 1.48. The receivables turnover for the company is 8.71for trailing twelve months and the total asset turnover is 1.78. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.00.
Conclusion
In summary, Rockwell Medical Inc (RMTI) has had a better performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
